Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/30/2872212/25416/en/Vaxart-Announces-Positive-Results-for-Its-Bivalent-Norovirus-Vaccine-Candidate-in-Lactating-Mothers.html
https://www.globenewswire.com/news-release/2024/03/27/2853084/25416/en/Vaxart-to-Present-at-World-Vaccine-Congress-Washington-2024-on-April-3.html
https://www.globenewswire.com/news-release/2024/03/20/2849335/25416/en/Vaxart-Inc-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com//news-release/2024/03/14/2846672/25416/en/Vaxart-Provides-Business-Update-and-Reports-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/03/07/2842178/25416/en/Vaxart-to-Host-Full-Year-2023-Business-Update-and-Financial-Results-Conference-Call-on-March-14.html
https://www.globenewswire.com//news-release/2024/03/06/2841361/25416/en/Vaxart-Inc-Appoints-Steven-Lo-as-President-Chief-Executive-Officer-and-Director.html
https://www.globenewswire.com//news-release/2024/02/05/2823462/25416/en/Vaxart-Announces-Publication-in-Vaccines-of-Non-Human-Primate-Preclinical-Data-Demonstrating-Its-Next-Generation-Vaccine-Candidates-Elicit-Mucosal-and-Systemic-Immunogenicity-and-R.html
https://www.globenewswire.com//news-release/2024/01/19/2812305/25416/en/Vaxart-Receives-9-27-Million-BARDA-Project-NextGen-Award-to-Prepare-for-Phase-2b-Clinical-Study-Evaluating-Its-COVID-19-Oral-Pill-Vaccine-Candidate.html
https://www.globenewswire.com//news-release/2024/01/16/2810011/25416/en/Vaxart-Announces-10-0-Million-Registered-Direct-Offering-with-RA-Capital-Management.html
https://www.globenewswire.com//news-release/2024/01/16/2810007/25416/en/Vaxart-Inc-Announces-Management-Change.html